| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 06/13/2002 | WO2002007646A3 Artificial vascular grafts, and methods of producing and using same |
| 06/13/2002 | WO2002006497A3 Transplastomic plants |
| 06/13/2002 | WO2002006325A3 32529, a human guanine nucleotide exchange factor family member and uses thereof |
| 06/13/2002 | WO2002004495A3 Streptococcus pyogenes antigen |
| 06/13/2002 | WO2002000716A3 Cell lines and cell-based assays for identification of androgen receptor modulators |
| 06/13/2002 | WO2002000701A3 Regulation of human gonadotropin releasing hormone receptor-like g protein-coupled receptor |
| 06/13/2002 | WO2002000252A3 Non-human animal models of tolerance to hepatitis c virus immunogenes |
| 06/13/2002 | WO2001098350A3 Compositions comprising net-4 modulations and their use for treating neoplastic disease |
| 06/13/2002 | WO2001096377A3 Vaccine for congenital tremors in pigs |
| 06/13/2002 | WO2001094564A3 Cis-zeatin o-glcocyltransferase from zea mays |
| 06/13/2002 | WO2001094547A3 Molecular delivery vehicle for delivery of selected compounds to targets |
| 06/13/2002 | WO2001094415A3 Nuclear hormone receptor |
| 06/13/2002 | WO2001094362A3 Haplotypes of the acp2 gene |
| 06/13/2002 | WO2001092503A3 Regulation of human calcium-independent alpha-latro-toxin-like g protein-coupled receptor |
| 06/13/2002 | WO2001092294A3 Therapeutic anti-melanoma compounds |
| 06/13/2002 | WO2001091781A3 Thrombospondin type 1 repeat polypeptides |
| 06/13/2002 | WO2001090322A3 32244, a novel human amp-binding enzyme and uses thereof |
| 06/13/2002 | WO2001090188A3 Receptor-based interaction trap |
| 06/13/2002 | WO2001090179A3 Novel human thrombospondin-like proteins and polynucleotides encoding the same |
| 06/13/2002 | WO2001090159A3 Compositions and methods for delivery of a molecule into a cell |
| 06/13/2002 | WO2001083687A3 A novel polypeptide, a human pax protein 23 and the polynucleotide encoding the polypeptide |
| 06/13/2002 | WO2001083685A3 A novel polypeptide, a cap protein 10 and the polynucleotide encoding the polypeptide |
| 06/13/2002 | WO2001083550A3 Gpr22 modulators as appetite-control agents |
| 06/13/2002 | WO2001083523A3 Stmst protein and nucleic acid molecules and uses therefor |
| 06/13/2002 | WO2001081607A3 Adenovirus vectors with knobless fibers, and their uses |
| 06/13/2002 | WO2001079425A3 A novel polypeptide - human chloride channel protein 10 and the polynucleotide encoding said polypeptide |
| 06/13/2002 | WO2001079289A3 Human interferon, zinf2 |
| 06/13/2002 | WO2001077168A3 Compositions and methods for the therapy and diagnosis of lung cancer |
| 06/13/2002 | WO2001075061A3 A novel polypeptide, cdv-1-42 and the polynucleotide encoding the polypeptide |
| 06/13/2002 | WO2001075020A3 A novel polypeptide, a human neuropolypeptide y 11 and the polynucleotide encoding the polypeptide |
| 06/13/2002 | WO2001075019A3 A novel polypeptide - human ataxia - telangiectasia mutein 11 andthe polynucleotide encoding said polypeptide |
| 06/13/2002 | WO2001075015A3 A novel polypeptide, fat24 and the polynucleotide encoding the polypeptide |
| 06/13/2002 | WO2001074844A3 Selective linear peptides with melanocortin-4 receptor (mc4-r) agonist activity |
| 06/13/2002 | WO2001072843A3 Regulation of human c-myb-related genes |
| 06/13/2002 | WO2001064889A3 Tnf-alpha variants for the treatment of tnf-alpha related disorders |
| 06/13/2002 | WO2001064836A3 Cloning of a gpr38 variant |
| 06/13/2002 | WO2001060860A3 Genes differentially expressed in human prostate cancer and their use |
| 06/13/2002 | WO2001059108A3 Inhibitors of apoptosis |
| 06/13/2002 | WO2001057242A3 Methods of protein destabilization and uses thereof |
| 06/13/2002 | WO2001049854A3 Increased lysine production by gene amplification using coryneform bacteria |
| 06/13/2002 | WO2001044300A3 Brain specific binding members |
| 06/13/2002 | WO2001042461A3 Apoptin-associating protein |
| 06/13/2002 | WO2001042291A3 Polynucleotides and polypeptides encoded thereby |
| 06/13/2002 | WO2001040280A3 Composition and method for treating a microbial infection |
| 06/13/2002 | WO2001038343A3 Covalently modified hemoglobin having low temperature-dependent oxygen-binding function |
| 06/13/2002 | WO2001029256A3 Cephalic pain susceptibility marker |
| 06/13/2002 | WO2001029239A3 Modified resistance genes |
| 06/13/2002 | WO2000077262A9 Synthetic ligation reassembly in directed evolution |
| 06/13/2002 | WO2000066741A3 Conserved neisserial antigens |
| 06/13/2002 | WO2000037610A3 Expression of immunogenic hepatitis b surface antigens in transgenic plants |
| 06/13/2002 | US20020073447 Acquired resistance genes and uses thereof |
| 06/13/2002 | US20020073442 Nucleotide sequences for use in the generation of disease resistant plants |
| 06/13/2002 | US20020073440 Screening for modulators of binding protein activity; obtain tissue, incubate with modulator, monitor activity of tissues |
| 06/13/2002 | US20020072861 Crystal structure of antibiotics bound to the 30S ribosome and its use |
| 06/13/2002 | US20020072596 Nucleotide sequences coding transrerrins; for use in the treatment of nervous system., blood abbd anemia, heme biosynthesis disorders |
| 06/13/2002 | US20020072595 Nucleic acid for use in kits for detection of preferential bacterial infection |
| 06/13/2002 | US20020072592 Nucleotide sequences which code anticarcinogenic agent for use in the treatment mammary gland cancer |
| 06/13/2002 | US20020072589 Insulin-like growth factor binding protein variants |
| 06/13/2002 | US20020072587 Crystal structure of estrogen receptor-beta complex and uses thereof |
| 06/13/2002 | US20020072586 Chiral peptide nucleic acids |
| 06/13/2002 | US20020072504 Method and reagents for genetic immunization |
| 06/13/2002 | US20020072503 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 06/13/2002 | US20020072497 Novel DNA and recombinant production of novel polypeptides |
| 06/13/2002 | US20020072496 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/13/2002 | US20020072494 Angiogenesis inhibitor, K1-5 (protease-activated kringles 1-5) genetically engineered so it can be secreted from cells in which it is expressed; contains a secretory signal peptide and a pre-activation peptide derived from plasminogen |
| 06/13/2002 | US20020072493 To promote nerve regeneration or to confer neuroprotection by administering the T cells or a nervous system-specific antigen such as myelin basic protein |
| 06/13/2002 | US20020072488 Amino acid sequences of human transporter peptides and proteins that are related to the sugar transporter subfamily; identifying modulators of the transporter peptides |
| 06/13/2002 | US20020072119 Preventing tumor growth; obtain cells, transform with expression vector, monitor cells for reduction in cell proliferation |
| 06/13/2002 | US20020072118 Method for preventing superoxide damage to cells and oxygen-labile proteins |
| 06/13/2002 | US20020072115 Pancreatic islet cell growth factors |
| 06/13/2002 | US20020072108 Generating freeze resistant peptides; obtain bacteria, culture under low temperatures, recover freeze resistant peptides |
| 06/13/2002 | US20020072107 Human osteoclast derived cathepsin |
| 06/13/2002 | US20020072105 Complex for use in generation of x-ray image of bacterial protein |
| 06/13/2002 | US20020072101 Novel human nucleic acid molecules and polypeptides encoding cation channels |
| 06/13/2002 | US20020072094 Generating viral particles; obtain nucleotide sequences, package into vector, insert vector into cells, induce viral particle assembly, recoevr viral particles |
| 06/13/2002 | US20020072092 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/13/2002 | US20020072091 Death domain containing receptor 5 |
| 06/13/2002 | US20020072090 Hr-1 receptor |
| 06/13/2002 | US20020072089 Novel ITALY, Lor-2, STRIFE, TRASH, BDSF, LRSG, and STMST protein and nucleic acid molecules and uses therefor |
| 06/13/2002 | US20020072088 Monitoring protein associations and activity; obtain cells, measuring expression of reporter genes, adjustment in expression indicates modulatory activity |
| 06/13/2002 | US20020072077 Nucleotide sequences coding enzymatic polypeptide; for use in bone marrow therapy |
| 06/13/2002 | US20020072067 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/13/2002 | US20020072066 Human osteoporosis gene |
| 06/13/2002 | US20020072052 Compositions and methods for regulating bacterial pathogenesis |
| 06/13/2002 | US20020071851 Borrelia burgdorferi bacterin |
| 06/13/2002 | US20020071850 Helicobacter pylori antigen |
| 06/13/2002 | US20020071849 A41L protein or a chemokine-binding fragment thereof; detecting an interaction of the chemokine-binding molecule with a chemokine; antiinflammatory agents |
| 06/13/2002 | US20020071847 Present on the surface of Borrelia burgdorferi cells that lack the outer membrane proteins OspA, OspB, OspC and OspD; sensitive to cleavage with proteinase K; having binding affinity for certain monoclonal antibodies |
| 06/13/2002 | US20020071846 Vaccines comprising oil bodies |
| 06/13/2002 | US20020071845 Vaccine for leptospirosis |
| 06/13/2002 | US20020071842 CD1 fusion proteins, preferably multivalent fusion proteins that are present in multimeric form (e.g., by Protein A binding multiple CD1 fusion proteins); diagnosis, vaccines |
| 06/13/2002 | US20020071841 Recombinant toxin and monoclonal antibody which specifically binds to glial-derived or meningioma-derived tumor cells; screening for malignant gliomas and meningiomas; treating glioblastoma multiforme and astrocytomas. |
| 06/13/2002 | US20020071834 Augmentation of wound healing by EIF4E mRNA and EGF mRNA |
| 06/13/2002 | US20020071831 Chlamydia antigens and corresponding DNA fragments and uses thereof |
| 06/13/2002 | US20020071830 Expression vector is used to express a polypeptide comprising the core protein of a human polymorphic epithelial mucin, which core protein is specifically bound by monoclonal antibody, SM3. |
| 06/13/2002 | US20020070506 Sealing assembly |
| 06/13/2002 | DE10154254A1 Elastic bush seal for automotive hub to wheel bearing zone |
| 06/13/2002 | DE10061334A1 Verwendung von aus embryonalen Stammzellen hergeleiteten Zellen zur Erhöhung der Transplantationstoleranz und zur Wiederherstellung zerstörten Gewebes Using derived from embryonic stem cells to increase transplant tolerance and restore damaged tissue |
| 06/13/2002 | DE10059336A1 Herstellung von rekombinantem BMP-2 Production of recombinant BMP-2 |
| 06/13/2002 | CA2767270A1 Phosphatase stress-related proteins and methods of use in plants |